Amsterdam, Netherlands Clinical Trials

A listing of Amsterdam, Netherlands clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 4 clinical trials
PEnile Cancer Radio- and Immunotherapy CLinical Exploration Study

Patients with advanced penile cancer have a poor prognosis (21% 2-year overall survival from moment of diagnosis) and high morbidity due to progressive locoregional disease. Translational studies show high rates of infiltrating immune cells and PD-L1 positivity, suggesting that immunotherapy may be beneficial in this disease. Atezolizumab, targeting PD-L1, is …

Netherlands Cancer Institute - Antoni van Leeuwenhoek
 (3.5 away) Contact site
  • 02 Apr, 2021
  • 1 location
A Study of AZD4635 With Durvalumab and With Cabazitaxel and Durvalumab in Patients With mCRPC.

This is a Phase II, international, open-label, two-arm, non-randomised study of AZD4635 in participants with metastatic castration-resistant prostate cancer (mCRPC).

Research Site
 (3.5 away) Contact site
  • 16 Jun, 2021
  • +42 other locations
Lutetium-177-PSMA-617 in Oligo-metastatic Hormone Sensitive Prostate Cancer

Radioligand therapy (RLT) using Lutetium-177 labelled PSMA is a promising new therapeutic approach to treat metastatic prostate cancer. This tumor-specific treatment is directed against prostate-specific membrane antigen (PSMA), which is overexpressed in prostate cancer cells. In the last few years, several lutetium-177 (177Lu, emitter) labeled PSMA ligands have been developed …

hormone therapy
Amsterdam UMC
 (0.2 away) Contact site
  • 04 Jun, 2021
  • +3 other locations
Hypofractionated Focal Lesion Ablative Microboost in prostatE Cancer 2.0

The hypo-FLAME 2.0 study is a multicenter phase II study (n=124) investigating the feasibility and safety of a reduction in the overall treatment time of radiotherapy for prostate cancer patients, making use of hypofractionated stereotactic body radiotherapy with focal boosting. We are looking for the optimal overall treatment time for …

The Netherlands Cancer Institute
 (3.5 away) Contact site
  • 27 Jan, 2021
  • +2 other locations